Plain-English translation of NCT06284577 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a daily probiotic supplement can help children with cystic fibrosis feel better and have healthier digestion. Researchers will compare children who take the medication with children who take a placebo (a dummy pill with no active ingredient) over six months. The study also looks at how the medication affects the bacteria in the gut and inflammation in the intestines.
Children with cystic fibrosis often struggle with digestive problems and poor gut health. Researchers want to know if adding probiotics to their care can reduce these problems and improve their overall quality of life.
You likely qualify if…
You likely don't qualify if…
If you join, you'll take a daily probiotic supplement (or placebo) for 6 months. You'll visit the hospital a few times to provide stool samples and answer questions about how you're feeling, especially about your digestion and quality of life. Researchers will track changes in your gut bacteria and inflammation before and after treatment.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Norway
Sponsor
Oslo University Hospital
Collaborators
Norwegian National Adivisory Unit on Rare Disorders
Enrollment target
~40 participants
Started
January 2024
Primary completion
June 2027
Age range
2 Years – 18 Years
Last updated on clinicaltrials.gov in June 2024.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.